{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:19Z","timestamp":1790949679618,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T00:00:00Z","timestamp":1484870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["This work was supported by an unrestricted grant f"],"award-info":[{"award-number":["This work was supported by an unrestricted grant f"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10067-017-3537-5","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T15:17:37Z","timestamp":1484925457000},"page":"1167-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Jose Ramon","family":"Maneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Gomez-Reino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"issue":"11","key":"3537_CR1","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70(11):1921\u20131925. doi: 10.1136\/ard.2011.151191","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3537_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/ard.2008.094839","volume":"68","author":"DD Gladman","year":"2009","unstructured":"Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68(7):1131\u20131135. doi: 10.1136\/ard.2008.094839","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3537_CR3","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID Rincon del","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12):2737\u20132745","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3537_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/art.21204","volume":"52","author":"NJ Goodson","year":"2005","unstructured":"Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52(8):2293\u20132299. doi: 10.1002\/art.21204","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3537_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","volume":"71","author":"CI Daien","year":"2012","unstructured":"Daien CI, Duny Y, Barnetche T, Daures JP, Combe B, Morel J (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71(6):862\u2013868. doi: 10.1136\/annrheumdis-2011-201148","journal-title":"Ann Rheum Dis"},{"key":"3537_CR6","doi-asserted-by":"publisher","unstructured":"Souto A, Salgado E, Maneiro JR, Mera A, Carmona L, Gomez-Reino JJ (2014) Lipid profile changes in patients with chronic inflammatory arthritis treated with biologics and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis & rheumatology (Hoboken, NJ). doi: 10.1002\/art.38894","DOI":"10.1002\/art.38894"},{"issue":"1","key":"3537_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jbspin.2009.05.012","volume":"77","author":"S Mathieu","year":"2010","unstructured":"Mathieu S, Dubost JJ, Tournadre A, Malochet-Guinamand S, Ristori JM, Soubrier M (2010) Effects of 14\u00a0weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis. Joint, bone, spine : revue du rhumatisme 77(1):50\u201352. doi: 10.1016\/j.jbspin.2009.05.012","journal-title":"Joint, bone, spine : revue du rhumatisme"},{"issue":"5","key":"3537_CR8","first-page":"921","volume":"33","author":"DN Kiortsis","year":"2006","unstructured":"Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33(5):921\u2013923","journal-title":"J Rheumatol"},{"issue":"5","key":"3537_CR9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.24492","volume":"60","author":"IC Eijk van","year":"2009","unstructured":"van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60(5):1324\u20131330. doi: 10.1002\/art.24492","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3537_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147(8):573\u2013577","journal-title":"Ann Intern Med"},{"issue":"4","key":"3537_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3537_CR12","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. doi: 10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3537_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/ard.2006.059691","volume":"66","author":"MJ Peters","year":"2007","unstructured":"Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF, Dijkmans BA, Twisk JW, de Koning MH, van de Stadt RJ, Nurmohamed MT (2007) Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis 66(7):958\u2013961. doi: 10.1136\/ard.2006.059691","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3537_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-2275(20)37610-0","volume":"37","author":"KR Feingold","year":"1996","unstructured":"Feingold KR, Spady DK, Pollock AS, Moser AH, Grunfeld C (1996) Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J Lipid Res 37(2):223\u2013228","journal-title":"J Lipid Res"},{"issue":"12","key":"3537_CR15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0022-2275(20)38211-0","volume":"30","author":"SK Fried","year":"1989","unstructured":"Fried SK, Zechner R (1989) Cachectin\/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 30(12):1917\u20131923","journal-title":"J Lipid Res"},{"issue":"5","key":"3537_CR16","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1210\/endo.132.5.8477669","volume":"132","author":"RA Memon","year":"1993","unstructured":"Memon RA, Grunfeld C, Moser AH, Feingold KR (1993) Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132(5):2246\u20132253. doi: 10.1210\/endo.132.5.8477669","journal-title":"Endocrinology"},{"issue":"11","key":"3537_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081145","volume":"8","author":"M Horie","year":"2013","unstructured":"Horie M, Noguchi S, Tanaka W, Goto Y, Yoshihara H, Kawakami M, Suzuki M, Sakamoto Y (2013) Relationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers. PLoS One 8(11):e81145. doi: 10.1371\/journal.pone.0081145","journal-title":"PLoS One"},{"issue":"9","key":"3537_CR18","first-page":"1746","volume":"31","author":"WH Yoo","year":"2004","unstructured":"Yoo WH (2004) Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 31(9):1746\u20131753","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3537-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T09:33:00Z","timestamp":1658482380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,20]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3537-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,20]]}}}